Lost in Translation: The Canadian Access to Medicines Regime from Transnational Activism to Domestic Implementation. Lost in Translation: The Canadian Access to Medicines Regime from Transnational Activism to Domestic Implementation.

Lost in Translation: The Canadian Access to Medicines Regime from Transnational Activism to Domestic Implementation‪.‬

Health Law Journal 2010, Annual, 18

    • £2.99
    • £2.99

Publisher Description

Canada was the first country to implement the WTO Decision of August 30, 2003, authorizing the export of generic drugs manufactured under a compulsory license to developing countries in response to a proposal brought forward by non-governmental organizations (NGOs) that now claim dissatisfaction with the Canadian legislation. This empirical case study examines what success means for an NGO campaign. It contrasts interviews, documents, media coverage, and public statements of stakeholders, using quantitative and qualitative analyses. It concludes the NGO network experienced a shift from a mobilizer of public sentiment at the international level to a policy adviser at the domestic level. This shift crystallized a change in leadership toward local, rather than transnational NGOs, and a shift in strategy from being radical to more reformist. While this process of institutionalizing the outcomes of international campaigns is necessary for the implementation of international norms into domestic policy, it required NGOs to compromise their ideal positions, producing some objective successes in legislative reform but subjective dissatisfaction of the NGOs in the failure of Canada's domestic regime to enhance access to medicines on the ground in developing countries. Introduction

GENRE
Health & Well-Being
RELEASED
2010
1 January
LANGUAGE
EN
English
LENGTH
62
Pages
PUBLISHER
Health Law Institute
SIZE
304.7
KB

More Books by Health Law Journal

All in the Family: A Child Welfare Perspective on Human Reproductive Cloning. All in the Family: A Child Welfare Perspective on Human Reproductive Cloning.
2003
Behind the Screen: Legal and Ethical Considerations in Neonatal Screening for Prenatal Exposure to Alcohol (Canada) Behind the Screen: Legal and Ethical Considerations in Neonatal Screening for Prenatal Exposure to Alcohol (Canada)
2006
History of a Gene Patent: Tracing the Development and Application of Commercial BRCA Testing (Myriad Genetics) History of a Gene Patent: Tracing the Development and Application of Commercial BRCA Testing (Myriad Genetics)
2002
Reconciling Private Benefit and Public Risk in Biotechnology: Xenotransplantation As a Case Study in Consent. Reconciling Private Benefit and Public Risk in Biotechnology: Xenotransplantation As a Case Study in Consent.
2002
A Place for Criminal Law in the Regulation of Reproductive Technologies (Canada ) A Place for Criminal Law in the Regulation of Reproductive Technologies (Canada )
2002
Cancer Surveillance in Canada: Analysis of Legal and Policy Frameworks and Tools for Reform. Cancer Surveillance in Canada: Analysis of Legal and Policy Frameworks and Tools for Reform.
2009